Results 151 to 160 of about 1,634 (161)

Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023–January 2024

Influenza and Other Respiratory Viruses
Sophie Vaux, Cecile Durand, Milesi Christophe   +2 more
exaly  

Acceptance and safety of the RSV-preventive treatment of newborns with nirsevimab in the maternity department: a prospective longitudinal cohort study in France

EClinicalMedicine
François Dubos
exaly  

Long-term impact of nirsevimab on prevention of respiratory syncytial virus infection using a real-world global database

Journal of Infection
Shinya Tsuzuki, Taito Kitano, Haruhisa Fukuda   +2 more
exaly  

Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants

Vaccine
April Killikelly
exaly  

Molecular and phenotypic characteristics of respiratory syncytial virus isolates recovered from medically vulnerable children: An exploratory analysis of a phase 2/3 randomized, double-blind, palivizumab-controlled trial of nirsevimab (MEDLEY)

Vaccine
Tonya Villafana, Vaishali S Mankad, Bahar Ahani   +2 more
exaly  

Will Nirsevimab Reduce the Burden on Public Health Care?—Reply

JAMA Pediatrics
Heidi L, Moline, Meredith L, McMorrow, Fatimah S, Dawood   +2 more
openaire   +2 more sources

Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study

Lancet Regional Health - Europe, The
Romain Anne-Sophie, Robert Cohen, Aurélie Bourmaud   +2 more
exaly  

Effectiveness of nirsevimab among infants in their first RSV season in the United States, October 2023–March 2024: a test-negative design analysis

The Lancet Regional Health Americas
Stephanie A Irving, Elizabeth Rowley, Brian E Dixon   +2 more
exaly  

Early Experiences With Nirsevimab: Perspectives From Newborn Hospitalists

Hospital Pediatrics
Elena, Aragona, Neha S, Joshi, Krista L, Birnie, Poj, Lysouvakon, Rakhi Gupta, Basuray   +4 more
openaire   +2 more sources

RSV vaccine and nirsevimab administration errors

Reactions Weekly
openaire   +1 more source